MARC Record from harvard_bibliographic_metadata

LEADER: 04193cam a2200553Ii 4500
001 013783939-1
005 20131004191557.0
006 m o d
008 130822s2013 it a o 001 0 eng d
020 $a9788847054158 (electronic bk.)
020 $a884705415X (electronic bk.)
020 $z9788847054141
024 7 $a10.1007/978-88-470-5415-8$2doi
035 0 $aocn856579119
040 $aGW5XE$erda$epn$cGW5XE$dN$T$dYDXCP$dE7B
050 4 $aRC685.H8
072 7 $aMB$2bicssc
072 7 $aMED000000$2bisacsh
072 7 $aHEA$x039000$2bisacsh
072 7 $aMED$x014000$2bisacsh
072 7 $aMED$x022000$2bisacsh
072 7 $aMED$x112000$2bisacsh
072 7 $aMED$x045000$2bisacsh
082 04 $a616.1/32$223
245 00 $aResistant hypertension :$bepidemiology, pathophysiology, diagnosis and treatment /$cGiuseppe Mancia, Editor.
264 1 $aMilan :$bSpringer,$c2013.
300 $a1 online resource (viii, 195 pages) :$billustrations (some color)
336 $atext$btxt$2rdacontent
337 $acomputer$bc$2rdamedia
338 $aonline resource$bcr$2rdacarrier
505 0 $aResistant Hypertension: Definition, Prevalence and Cardiovascular Risk -- Resistant Hypertension: Neurohumoral Aspects -- Metabolic Alterations -- Cardiac and Vascular Alterations in Resistant Hypertension -- The Pathophysiology of the Kidney in Resistant Hypertension -- False vs. True Resistant Hypertension -- Causes of Resistant Hypertension -- 24-hour Ambulatory BP Monitoring and Home BP Measurements in Resistant Hypertension -- Factors Predicting Blood Pressure Response to Treatment -- Treatment of Resistant Hypertension: Which Additional Antihypertensive Drugs? -- The Role of Renal Denervation -- The Role of Carotid Baroreceptor Stimulation -- Pathophysiology: Metabolic Alterations and Risk Factors -- Follow-up of Patients with Resistant Hypertension -- Resistant Hypertension: Cost-Benefit Considerations -- Involvement of Health Professionals From the General Practitioner to the Hypertension Specialist and the Hypertension Center.
520 $aA growing number of people suffer from so-called resistant hypertension, that is to say, high blood pressure that does not respond to treatment. This disorder is of great current interest and importance for public health, being a common clinical problem faced by both primary care clinicians and specialists. Furthermore, as older age and obesity are among the strongest risk factors for uncontrolled hypertension, the incidence of resistant hypertension will likely increase as the population becomes more elderly and heavier. While the prognosis of resistant hypertension is unknown, cardiovascular risk is undoubtedly increased since patients often have a history of long-standing, severe hypertension complicated by multiple other cardiovascular risk factors. This volume, compiled by a panel of world-renowned experts, offers a comprehensive exploration of resistant hypertension, covering epidemiology, complex diagnostic aspects, and the therapeutic options currently available, with due attention to overall treatment strategies. New therapeutic agents and procedures, such as renal denervation and baroreceptor stimulation, are also described. In addition, the book addresses the economic aspects of resistant hypertension and the role of the different professional figures, from GPs to hypertension specialists, in dealing with it.
500 $aIncludes index.
588 $aDescription based on online resource; title from PDF title page (SpringerLink, viewed August 20, 2013).
538 $aMode of access: World Wide Web.
650 7 $aMEDICAL / Internal Medicine.$2bisacsh
650 7 $aMEDICAL / Evidence-Based Medicine.$2bisacsh
650 7 $aMEDICAL / Diseases.$2bisacsh
650 7 $aMEDICAL / Clinical Medicine.$2bisacsh
650 7 $aHEALTH & FITNESS / Diseases / General.$2bisacsh
650 20 $aPrimary care (Medicine)
650 20 $aCardiology.
650 20 $aInternal medicine.
650 0 $aHypertension.
650 0 $aHypertension$xDiagnosis.
650 0 $aHypertension$xTreatment.
650 14 $aMedicine & Public Health.
988 $a20130921
906 $0OCLC